• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Treatment of hypercalcaemia associated with malignancy.与恶性肿瘤相关的高钙血症的治疗。
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):812-3. doi: 10.1136/bmj.288.6420.812.
2
[Treatment of malignancy associated hypercalcemia].[恶性肿瘤相关性高钙血症的治疗]
Clin Calcium. 2014 Aug;24(8):1223-8.
3
Mechanisms and treatment of hypercalcemia of malignancy.恶性肿瘤高钙血症的发病机制与治疗。
Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):339-46. doi: 10.1097/MED.0b013e32834b4401.
4
Bone physiology. Hypercalcaemia of malignancy.骨生理学。恶性肿瘤高钙血症。
Nature. 1988 Nov 24;336(6197):311. doi: 10.1038/336311a0.
5
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.氯膦酸盐。其药理学特性及对溶骨性骨病治疗效果的综述。
Drugs. 1994 Jun;47(6):945-82. doi: 10.2165/00003495-199447060-00007.
6
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.联合应用氨基羟丙基二膦酸盐和降钙素治疗癌症相关性高钙血症
Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1549-50. doi: 10.1136/bmj.292.6535.1549.
7
Treatment of hypercalcemia of malignancy with bisphosphonates.使用双膦酸盐治疗恶性肿瘤引起的高钙血症。
Semin Oncol. 2002 Dec;29(6 Suppl 21):12-8. doi: 10.1053/sonc.2002.37417.
8
[The significance of early diagnosis of cancer-related hypercalcaemia].[癌症相关高钙血症早期诊断的意义]
Orv Hetil. 2013 Sep 1;154(35):1367-73. doi: 10.1556/OH.2013.29665.
9
Hypercalcaemia of malignancy.恶性肿瘤高钙血症
N Z Med J. 1993 Aug 11;106(961):341-3.
10
Hypercalcaemia and malignancy.高钙血症与恶性肿瘤
Ann Clin Biochem. 1976 Nov;13(6):555-60. doi: 10.1177/000456327601300159.

引用本文的文献

1
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations.降钙素与骨生理学：体外、体内及临床研究
Int J Endocrinol. 2020 Sep 10;2020:3236828. doi: 10.1155/2020/3236828. eCollection 2020.
2
Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.在人破骨细胞样细胞分化过程中，降钙素对降钙素受体mRNA表达的下调作用。
J Clin Invest. 1995 Jan;95(1):167-71. doi: 10.1172/JCI117634.
3
Palliative medicine.姑息医学
Postgrad Med J. 1993 Jun;69(812):429-49. doi: 10.1136/pgmj.69.812.429.
4
Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.用于治疗代谢性骨病的药物。临床药理学与治疗用途。
Drugs. 1993 Oct;46(4):594-617. doi: 10.2165/00003495-199346040-00003.
5
Treatment of malignant hypercalcaemia with clodronate.用氯膦酸盐治疗恶性高钙血症。
Br J Cancer. 1985 May;51(5):665-9. doi: 10.1038/bjc.1985.100.
6
Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.单次大剂量输注氨羟丙基二膦酸盐对癌症所致高钙血症的影响。
Br Med J (Clin Res Ed). 1987 Feb 21;294(6570):467-9. doi: 10.1136/bmj.294.6570.467.
7
Potentiation of calcitonin by corticosteroids during the treatment of the hypercalcaemia of malignancy.在恶性肿瘤高钙血症治疗期间皮质类固醇对降钙素的增强作用。
Eur J Clin Pharmacol. 1990;38(1):37-41. doi: 10.1007/BF00314800.
8
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.帕米膦酸盐。其药理学特性及在溶骨性骨病中治疗效果的综述。
Drugs. 1991 Feb;41(2):289-318. doi: 10.2165/00003495-199141020-00009.

本文引用的文献

1
Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.降钙素与糖皮质激素联合应用对恶性肿瘤高钙血症的影响。
Ann Intern Med. 1980 Aug;93(2):269-72. doi: 10.7326/0003-4819-93-2-269.
2
Rehydration in the treatment of severe hypercalcaemia.
Q J Med. 1981 Autumn;50(200):473-81.
3
A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.恶性肿瘤高钙血症患者中前列腺素E2、甲状旁腺激素及对吲哚美辛反应的研究
Cancer. 1982 Feb 1;49(3):556-61. doi: 10.1002/1097-0142(19820201)49:3<556::aid-cncr2820490327>3.0.co;2-z.
4
Hypercalcaemia--a hospital survey.高钙血症——一项医院调查。
Q J Med. 1980 Autumn;49(196):405-18.
5
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.两种胃肠外双膦酸盐治疗恶性肿瘤高钙血症的比较。
Am J Med. 1982 Feb;72(2):221-6. doi: 10.1016/0002-9343(82)90813-0.
6
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.恶性肿瘤高钙血症：静脉注射二氯亚甲基二膦酸盐治疗
Ann Intern Med. 1981 Mar;94(3):312-6. doi: 10.7326/0003-4819-94-3-312.
7
Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.二氯亚甲基二膦酸二钠对骨转移所致高钙血症的影响。
J Clin Invest. 1980 May;65(5):1243-7. doi: 10.1172/JCI109780.
8
Disequilibrium hypercalcaemia.失衡性高钙血症
Br Med J (Clin Res Ed). 1983 Jan 29;286(6362):326-7. doi: 10.1136/bmj.286.6362.326.
9
Comparative study of available medical therapy for hypercalcemia of malignancy.恶性肿瘤高钙血症现有医学治疗方法的比较研究
Am J Med. 1983 Mar;74(3):421-32. doi: 10.1016/0002-9343(83)90961-0.
10
Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia.
Lancet. 1983 Jul 30;2(8344):239-43. doi: 10.1016/s0140-6736(83)90231-3.

Treatment of hypercalcaemia associated with malignancy.

作者信息

Wilkinson R

出版信息

Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):812-3. doi: 10.1136/bmj.288.6420.812.

DOI:10.1136/bmj.288.6420.812
PMID:6423093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1441596/
Abstract
摘要